Steven Lo's most recent trade in OmniAb Inc was a trade of 40,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OmniAb Inc | Steven Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| OmniAb Inc | Steven Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 20,000 | 46,667 | - | - | Restricted Stock Units | |
| OmniAb Inc | Steven Love | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2025 | 20,000 | 26,667 | - | - | Restricted Stock Units | |
| OmniAb Inc | Steven Love | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2025 | 20,000 | 58,333 | - | - | Common Stock | |
| Zumiez Inc | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 7,154 | 25,225 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Steven Lo | Director, President, Chief Exec Officer | Purchase of securities on an exchange or from another person at price $ 0.49 per share. | 19 May 2025 | 100,000 | 100,000 (0%) | 0% | 0.5 | 49,000 | Common Stock |
| OmniAb Inc | Steven Love | Director | Purchase of securities on an exchange or from another person at price $ 1.46 per share. | 14 May 2025 | 25,000 | 38,333 | - | 1.5 | 36,500 | Common Stock |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 3,528 | 63,900 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,154 | 65,054 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Steven Lo | Director, President, Chief Exec Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 2,108,000 | 2,108,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Steven Lo | Director, President, Chief Exec Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 1,405,000 | 1,632,638 (3%) | 2% | 0 | Common Stock | |
| Vaxart Inc | Steven Lo | Director, President, Chief Exec Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. | 18 Mar 2025 | 22,362 | 227,638 (0%) | 0% | 0.6 | 12,751 | Common Stock |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.32 per share. | 14 Feb 2025 | 5,739 | 66,111 (0%) | 0% | 45.3 | 260,073 | Common Stock |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,739 | 0 | - | - | Director Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Sale of securities on an exchange or to another person at price $ 76.42 per share. | 14 Feb 2025 | 5,739 | 60,372 (0%) | 0% | 76.4 | 438,576 | Common Stock |
| OmniAb Inc | Steven Love | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 13,333 | 46,667 | - | - | Restricted Stock Units | |
| OmniAb Inc | Steven Love | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 13,333 | 13,333 | - | - | Common Stock | |
| OmniAb Inc | Steven Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| OmniAb Inc | Steven Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 20,000 | 60,000 | - | - | Restricted Stock Units | |
| Zumiez Inc | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 4,655 | 18,071 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,134 | 30,134 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 10,044 | 441,873 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 10,044 | 0 | - | - | Restricted Stock Units | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 3,055 | 59,373 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 999 | 60,372 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Steven Lo | Director, President, Chief Exec Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 1,000,000 | 1,000,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Steven Lo | Director, President, Chief Exec Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 250,000 | 250,000 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Steven Louden P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 12,020 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | P. Louden Steven | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 12,020 | 34,746 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Louden P. Steven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 12,020 | 12,020 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | P. Louden Steven | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 10,483 | 22,726 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Louden P. Steven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2023 | 10,483 | 10,483 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven Louden P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 10,483 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven P. Louden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 6,143 | 12,243 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 6,143 | 6,143 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven P. Louden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 6,143 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Zumiez Inc | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 5,600 | 13,416 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 10,044 | 10,044 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 9,513 | 0 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 9,513 | 431,829 (1%) | 0% | 0 | Common Stock | |
| Xylem Inc | Steven R. Loranger | Director | 18 May 2023 | 1,580 | 13,818 (0%) | 0% | 0 | Common Stock | ||
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 55,420 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 898 | 56,318 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Steven P. Louden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 6,100 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 6,100 | 6,100 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven P. Louden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 6,100 | 6,100 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2023 | 51,829 | 422,316 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2023 | 51,829 | 0 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 18.47 per share. | 30 Aug 2022 | 139,072 | 370,487 (1%) | 0% | 18.5 | 2,569,272 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Aug 2022 | 3,000 | 509,559 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 30 Aug 2022 | 482 | 512,559 (1%) | 0% | 19 | 9,158 | Common Stock |
| Roku Inc - Ordinary Shares... | Steven P. Louden | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 145,730 | 145,730 | - | - | Employee Stock Option (right to buy) | |
| Roku Inc - Ordinary Shares... | Steven P. Louden | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 19,790 | 19,790 | - | - | Employee Stock Option (right to buy) | |
| Saratoga Investment Corp | Steven M. Looney | Director | Purchase of securities on an exchange or from another person at price $ 23.54 per share. | 02 Aug 2022 | 1,250 | 3,758 (0%) | 0% | 23.5 | 29,425 | Common Stock |
| Zumiez Inc | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,729 | 7,816 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 9,513 | 9,513 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2022 | 2,335 | 513,041 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2022 | 2,335 | 0 | - | - | Restricted Stock Units | |
| Xylem Inc | Steven R. Loranger | Director | 12 May 2022 | 1,812 | 12,238 (0%) | 0% | 0 | Common Stock | ||
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 2,300 | 51,880 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 737 | 52,617 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 23,261 | 510,706 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 23,261 | 0 | - | - | Restricted Stock Units | |
| Xylem Inc | Steven R. Loranger | Director | 31 Dec 2021 | 12,491 | 46,407 (0%) | 0% | 0 | Common Stock | ||
| TPI Composites Inc | Steven C. Lockard | Director | Purchase of securities on an exchange or from another person at price $ 14.49 per share. | 15 Dec 2021 | 3,000 | 428,702 (1%) | 0% | 14.5 | 43,469 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 2,335 | 2,335 | - | - | Restricted Stock Units | |
| Xylem Inc | Steven R. Loranger | Director | 12 May 2021 | 1,328 | 22,293 (0%) | 0% | 0 | Common Stock | ||
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 158,593 | 66,537 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 11 May 2021 | 158,593 | 584,295 (1%) | 0% | 10.9 | 1,724,255 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 11 May 2021 | 157,793 | 426,502 (1%) | 0% | 45.0 | 7,100,401 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 66,537 | 0 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 43.20 per share. | 11 May 2021 | 66,537 | 425,702 (1%) | 0% | 43.2 | 2,874,272 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 11 May 2021 | 66,537 | 492,239 (1%) | 0% | 10.9 | 723,404 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 45.44 per share. | 11 May 2021 | 800 | 425,702 (1%) | 0% | 45.4 | 36,352 | Common Stock |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 3,270 | 3,270 | - | - | Director Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 2,615 | 49,580 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 23,522 | 425,702 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 23,522 | 0 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2020 | 197,315 | 216,130 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 30 Nov 2020 | 197,315 | 542,751 (1%) | 0% | 10.9 | 2,145,248 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 39.97 per share. | 30 Nov 2020 | 120,208 | 422,543 (1%) | 0% | 40.0 | 4,805,086 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.92 per share. | 30 Nov 2020 | 41,034 | 381,509 (1%) | 0% | 40.9 | 1,679,255 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 41.70 per share. | 30 Nov 2020 | 36,073 | 345,436 (0%) | 0% | 41.7 | 1,504,132 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 23 Nov 2020 | 111,065 | 456,501 (1%) | 0% | 10.9 | 1,207,521 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 111,065 | 413,445 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 38.63 per share. | 23 Nov 2020 | 71,221 | 385,280 (1%) | 0% | 38.6 | 2,751,474 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 38,935 | 524,510 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.25 per share. | 23 Nov 2020 | 38,935 | 345,436 (0%) | 0% | 40.3 | 1,567,286 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 23 Nov 2020 | 38,935 | 384,371 (1%) | 0% | 10.9 | 423,309 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 39.69 per share. | 23 Nov 2020 | 38,044 | 347,236 (0%) | 0% | 39.7 | 1,509,993 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.23 per share. | 23 Nov 2020 | 1,800 | 345,436 (0%) | 0% | 40.2 | 72,408 | Common Stock |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 19,797 | 0 | - | - | Director Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 16 Nov 2020 | 19,797 | 46,965 (0%) | 0% | 35.2 | 696,789 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 13 Nov 2020 | 103,166 | 448,602 (1%) | 0% | 10.9 | 1,121,641 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 103,166 | 612,964 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.25 per share. | 13 Nov 2020 | 98,695 | 349,907 (0%) | 0% | 40.3 | 3,972,632 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 42,647 | 563,445 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 13 Nov 2020 | 42,647 | 345,436 (0%) | 0% | 40 | 1,705,880 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 13 Nov 2020 | 42,647 | 388,083 (1%) | 0% | 10.9 | 463,667 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 6,872 | 606,092 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.11 per share. | 13 Nov 2020 | 6,872 | 345,436 (0%) | 0% | 40.1 | 275,618 | Common Stock |